Evidence map›Paper›PMID 34032859›Full record

ArticleThe Journal of experimental medicine2021

Aged hematopoietic stem cells are refractory to bloodborne systemic rejuvenation interventions.

Theodore T Ho, Paul V Dellorusso, Evgenia V Verovskaya, Sietske T Bakker, Johanna Flach, Lucas K Smith, Patrick B Ventura, Olivia M Lansinger, Aurélie Hérault, Si Yi Zhang and 4 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
10.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 93 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Aged circulating CD8Immunity · 2026
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Ageing, immune fitness and cancer.Nature reviews. Cancer · 2025
    Review
  17. Article
  18. The systemic costs of hematopoietic stem cell aging.Development (Cambridge, England) · 2025
    Review
  19. Review
  20. Review

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Theodore T Ho *The Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research, Department of Medicine, Hematology/Oncology Division, University of California, San Francisco, San Francisco, CA.ORCID 0000-0001-8395-5547
Paul V Dellorusso *Columbia Stem Cell Initiative, Department of Genetics and Development, Columbia University Irving Medical Center, New York, NY.ORCID 0000-0002-9501-1313
Evgenia V Verovskaya *The Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research, Department of Medicine, Hematology/Oncology Division, University of California, San Francisco, San Francisco, CA.ORCID 0000-0003-1882-7850
Sietske T BakkerThe Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research, Department of Medicine, Hematology/Oncology Division, University of California, San Francisco, San Francisco, CA.ORCID 0000-0003-4962-3594
Johanna FlachThe Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research, Department of Medicine, Hematology/Oncology Division, University of California, San Francisco, San Francisco, CA.ORCID 0000-0001-6157-8357
Lucas K SmithDepartment of Anatomy, University of California, San Francisco, San Francisco, CA.ORCID 0000-0003-3452-6177
Patrick B VenturaDepartment of Anatomy, University of California, San Francisco, San Francisco, CA.ORCID 0000-0001-5001-0993
Olivia M LansingerThe Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research, Department of Medicine, Hematology/Oncology Division, University of California, San Francisco, San Francisco, CA.ORCID 0000-0002-3883-4524
Aurélie HéraultThe Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research, Department of Medicine, Hematology/Oncology Division, University of California, San Francisco, San Francisco, CA.ORCID 0000-0002-8950-1009
Si Yi ZhangThe Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research, Department of Medicine, Hematology/Oncology Division, University of California, San Francisco, San Francisco, CA.ORCID 0000-0002-5793-1151
Yoon-A KangThe Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research, Department of Medicine, Hematology/Oncology Division, University of California, San Francisco, San Francisco, CA.ORCID 0000-0002-0978-5348
Carl A MitchellColumbia Stem Cell Initiative, Department of Genetics and Development, Columbia University Irving Medical Center, New York, NY.ORCID 0000-0003-2704-9763
Saul A VilledaDepartment of Anatomy, University of California, San Francisco, San Francisco, CA.ORCID 0000-0002-2726-9582
Emmanuelle PasseguéThe Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research, Department of Medicine, Hematology/Oncology Division, University of California, San Francisco, San Francisco, CA.ORCID 0000-0002-3516-297X
University of California, San Francisco · USColumbia University · US

Funding

TRAINING IN CELLULAR, MOLECULAR AND BIOPHYSICAL STUDIEST32GM008224 · NIGMS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI LIEM, RONALD K. · 1987 to 2021
$9.9M
Emergency Myelopoiesis Pathways in the Control of Blood ProductionR35HL135763 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI PASSEGUE, EMMANUELLE · 2017 to 2023
$5.7M
Investigating the pro-aging role of B2M and MHC molecules on regenerative and cognitive function in the brainR01AG055797 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI VILLEDA, SAUL A · 2017 to 2021
$1.6M
Autophagy Engagement and Hematopoietic Stem Cell Maintenance During AgingF31HL151140 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI DELLORUSSO, PAUL VINCENT · 2020 to 2021
$90k
NHLBI NIH HHS F31 HL151140NHLBI NIH HHS R35 HL135763NIA NIH HHS R01 AG055797NIGMS NIH HHS T32 GM008224
6 · The paper itself

Abstract

While young blood can restore many aged tissues, its effects on the aged blood system itself and old hematopoietic stem cells (HSCs) have not been determined. Here, we used transplantation, parabiosis, plasma transfer, exercise, calorie restriction, and aging mutant mice to understand the effects of age-regulated systemic factors on HSCs and their bone marrow (BM) niche. We found that neither exposure to young blood, nor long-term residence in young niches after parabiont separation, nor direct heterochronic transplantation had any observable rejuvenating effects on old HSCs. Likewise, exercise and calorie restriction did not improve old HSC function, nor old BM niches. Conversely, young HSCs were not affected by systemic pro-aging conditions, and HSC function was not impacted by mutations influencing organismal aging in established long-lived or progeroid genetic models. Therefore, the blood system that carries factors with either rejuvenating or pro-aging properties for many other tissues is itself refractory to those factors.

Indexed as

AgingAnimalsBone MarrowHematopoietic Stem CellsMiceMice, Inbred C57BLMice, Inbred NODMice, SCIDMutationRejuvenation

Identifiers

PMID34032859
PMCPMC8155813
OpenAlexW3165498186

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.